Uveitis is a major cause of blindness in the United States. Pars planitis is a well-defined disease subset of uveitis. The causes of pars planitis, as well as other uveitis subsets, are frequently unknown. The overall objective of this project is to characterize a distinctive protein, called P-36, which we have identified in the plasma/serum of pars planitis patients during acute exacerbation of the disease, and to investigate its possible role in the pathogenesis of pars planitis. The identification of a protein which may contribute to the pathogenesis of pars planitis would be a major advance toward its treatment and possible cure. We propose the following specific aims: A. To identify P-36 in the plasma/serum of pars planitis patients, to quantitate its levels in patient's plasma/serum, to correlate P-36 levels with disease activity, and to determine whether it circulates freely or as a part of a larger molecular complex. B. To identity and characterize P-36 in the eye. C. To identity a potential biological function for P-36. Quantitative assessment of P-36 levels in patients' plasma/serum may be of value in both monitoring disease activity and guiding treatment. The proposed study would provide the precise structural information about the protein. Studies involving functional properties of P-36 will help us in understanding the mechanism of ocular inflammation in pars planitis and possibly to design more effective treatment for this disease.
Showing the most recent 10 out of 18 publications
